Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
Medtronic -- According to my calculations from the most recent 10Q (which means I haven't adjusted out a couple of recent charges that lower the numbers), they pass all the numerical CK criteria, other than the flow ratio.

Gross Margin -- 74.5%
Net Margin -- 15.5%
Leveraged Flow -- 1.97
Unleveraged Flow -- 2.34
Cash/Debt -- 20

As with nearly all medical companies, they do fall short on consumer mindshare as consumers generally do not buy their products. But, they seem to have great mindshare among their core customers. They have a dominant share of the market for pacemakers and some other medical devices as well. I think our portfolio needs another medical stock, and I think that this one, which is lesser known than the pharmaceuticals is a worthy candidate.

The stock's performance over the years certainly speaks for itself.

Personally, I like the direction as well. EPS has grown by nearly 25% over the last 5 years and is expected to grow just under 19% over the next 5.

The rather high "flowie" and the rather slow turnover of receivables are both strikes against this one.

Phil

Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.